T.Man Pharmaceutical PCL Cash Flow Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	523.07	450.7	431.09	472.52	56.39
Depreciation & Amortization	126.11	104.83	97.87	75.09	70.36
Loss (Gain) From Sale of Assets	-0.21	-0.35	-0.58	3.52	0.17
Asset Writedown & Restructuring Costs	67.54	0.07	0.01	-	-
Provision & Write-off of Bad Debts	5.93	-3.29	-44.63	40.57	11.64
Other Operating Activities	-41.6	21.27	-66.84	101.77	16.04
Change in Accounts Receivable	-354.23	7.38	-42.97	-289.24	-76.82
Change in Inventory	-112.36	-59.79	-125.25	-62.83	101.77
Change in Accounts Payable	90.58	34.98	3.49	65.99	101.17
Change in Unearned Revenue	28.68	-28.28	26.49	-	-
Change in Other Net Operating Assets	2.94	-7.85	3.41	116.13	-5
Operating Cash Flow	336.44	519.66	282.09	523.53	275.74
Operating Cash Flow Growth	-35.26%	84.22%	-46.12%	89.86%	42.09%
Capital Expenditures	-226.44	-173.95	-219.95	-234.52	-79.25
Sale of Property, Plant & Equipment	0.21	1.09	2.33	-	1.21
Sale (Purchase) of Real Estate	-	-	-	37.07	-
Investment in Securities	297.7	-650	-	-	5
Other Investing Activities	59.65	1.83	1.24	20.08	0.05
Investing Cash Flow	131.12	-821.03	-216.38	-177.36	-72.99
Short-Term Debt Issued	-	929.11	28.81	-	19.61
Long-Term Debt Issued	-	-	-	50	-
Total Debt Issued	-	929.11	28.81	50	19.61
Short-Term Debt Repaid	-205	-352.54	-60.38	-79.57	-210.2
Long-Term Debt Repaid	-7.28	-40.52	-32.82	-22.8	-50.84
Total Debt Repaid	-212.28	-393.06	-93.2	-102.37	-261.04
Net Debt Issued (Repaid)	-212.28	536.05	-64.4	-52.37	-241.43
Issuance of Common Stock	-	1,164	59.13	-	-
Common Dividends Paid	-175.91	-1,336	-11.83	-	-
Other Financing Activities	-28.44	-62.99	-7.75	-8.82	-6.03
Financing Cash Flow	-416.63	301.72	-24.85	-61.19	-247.46
Net Cash Flow	50.93	0.35	40.86	284.98	-44.71
Free Cash Flow	110	345.71	62.15	289.02	196.49
Free Cash Flow Growth	-68.18%	456.28%	-78.50%	47.09%	52.52%
Free Cash Flow Margin	4.35%	15.53%	3.14%	14.27%	15.55%
Free Cash Flow Per Share	0.28	1.01	0.23	1.16	2.72
Cash Interest Paid	28.44	34.58	7.75	8.62	6.03
Cash Income Tax Paid	74.54	77.68	164.55	50.32	14.53
Levered Free Cash Flow	-61.87	216.02	-46.49	159.27	193.69
Unlevered Free Cash Flow	-44.1	227.66	-37.2	169.88	198.18
Change in Working Capital	-344.39	-53.57	-134.83	-169.95	121.13

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.